The feasibility study of FOLFOX therapy in gastrointestinal cancer patients undergoing hemodialysis
Not Applicable
Recruiting
- Conditions
- Esophageal cancer, gastric cancer, small bowel cancer, colorectal cancer
- Registration Number
- JPRN-jRCTs051190120
- Lead Sponsor
- Manabu Muto
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
1. Patients undergoing hemodialysis.
2. Patients diagnosed as gastrointestinal cancer.
3. Less than 80years old, and PS is 0-1.
4. Organ functions other than renal function are maintained.
5. Chemotherapy naive case.
6. The written consent can be obtained from patients.
Exclusion Criteria
1. Hyperammonemia within 14 days befere registration.
2. Patients with Grade 2 peripheral sensory neuropathy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method